Holen Sie sich die Stockscreener-App
78.52
2.25%
-1.81
Vorhandelsmarkt:
79.46
0.94
+1.20%
Schlusskurs vom Vortag:
$80.33
Offen:
$81.36
24-Stunden-Volumen:
338.82K
Relative Volume:
0.89
Marktkapitalisierung:
$1.70B
Einnahmen:
$747.40M
Nettoeinkommen (Verlust:
$-12.60M
KGV:
-102.15
EPS:
-0.7687
Netto-Cashflow:
$105.18M
1W Leistung:
-7.13%
1M Leistung:
-17.45%
6M Leistung:
+29.49%
1J Leistung:
+42.50%
1-Tages-Spanne:
$78.15
$82.12
1-Wochen-Bereich:
$78.15
$85.17
52-Wochen-Spanne:
$52.50
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Firmenname
Ani Pharmaceuticals Inc
Sektor
Telefon
(218) 634-3500
Adresse
210 MAIN STREET WEST, BAUDETTE, MN
Vergleichen Sie ANIP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
78.52 | 1.80B | 747.40M | -12.60M | 105.18M | -0.7687 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-03-12 | Eingeleitet | JP Morgan | Overweight |
| 2024-12-11 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-11 | Eingeleitet | Piper Sandler | Overweight |
| 2024-03-15 | Eingeleitet | CapitalOne | Overweight |
| 2023-08-22 | Bestätigt | H.C. Wainwright | Buy |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-02 | Eingeleitet | Truist | Buy |
| 2020-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-05-10 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Bestätigt | Canaccord Genuity | Buy |
| 2017-07-31 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-02-22 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Eingeleitet | Raymond James | Strong Buy |
| 2016-05-24 | Herabstufung | Standpoint Research | Buy → Hold |
| 2015-11-13 | Eingeleitet | Standpoint Research | Buy |
| 2015-09-28 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Bestätigt | Oppenheimer | Outperform |
| 2015-08-04 | Bestätigt | ROTH Capital | Neutral |
| 2015-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2015-07-15 | Bestätigt | ROTH Capital | Neutral |
| 2015-06-23 | Bestätigt | Oppenheimer | Outperform |
| 2015-05-18 | Bestätigt | ROTH Capital | Neutral |
| 2015-05-06 | Bestätigt | Oppenheimer | Outperform |
| 2015-04-10 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Bestätigt | ROTH Capital | Buy |
| 2015-02-18 | Bestätigt | Oppenheimer | Outperform |
Alle ansehen
Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten
Will ANI Pharmaceuticals Inc. stock maintain momentum in 20252025 Market WrapUp & Weekly Chart Analysis and Guides - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock deliver compounding returnsExit Point & Entry Point Confirmation Signals - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock remain on Wall Street radarQuarterly Earnings Report & Safe Capital Growth Tips - newser.com
Why hedge funds are buying ANI Pharmaceuticals Inc. stock2025 Top Gainers & Capital Efficient Trade Techniques - newser.com
Can ANI Pharmaceuticals Inc. (BSFA) stock stage a strong rebound this quarter2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock sustain uptrend momentum2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
What consensus target says about ANI Pharmaceuticals Inc. (BSFA) stockTreasury Yields & AI Powered Trade Plan Recommendations - newser.com
Is ANI Pharmaceuticals Inc. (BSFA) stock a buy for dividend portfoliosDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com
Is ANI Pharmaceuticals Inc. stock attractive for long term wealth buildingPortfolio Growth Summary & Stock Timing and Entry Methods - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock announce special dividendJuly 2025 Technicals & AI Driven Price Forecasts - newser.com
Published on: 2025-11-19 18:22:56 - newser.com
What insider trading reveals about ANI Pharmaceuticals Inc. stockMarket Trend Review & Weekly Hot Stock Watchlists - newser.com
Why ANI Pharmaceuticals Inc. stock could rally in 2025Short Setup & Weekly Chart Analysis and Guides - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock announce a stock splitJuly 2025 Analyst Calls & Growth Focused Investment Plans - newser.com
ANI (ANIP) Loses 15% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Is ANI Pharmaceuticals Inc. stock attractive for growth ETFsWeekly Trend Summary & Weekly Breakout Watchlists - newser.com
Why ANI Pharmaceuticals Inc. (BSFA) stock is a strong buy call2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Is ANI Pharmaceuticals Inc. (BSFA) stock undervalued historicallyJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com
Why ANI Pharmaceuticals Inc. (BSFA) stock attracts HNW investorsMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Can ANI Pharmaceuticals Inc. stock continue upward trend2025 Market Trends & Daily Growth Stock Investment Tips - newser.com
Published on: 2025-11-19 01:10:17 - newser.com
What high frequency data says about ANI Pharmaceuticals Inc.Buy Signal & Safe Capital Growth Plans - newser.com
Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.17%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):